Scientific highlights


Helmholtz Diabetes Conference opened by Federal Minister Karliczek

One hundred after the discovery of insulin turned diabetes from a deadly disease into a manageable illness, the 8th Helmholtz Diabetes Conference is hosting world-leading researchers to share their latest findings. This year, Anja Karliczek, Germany’s Federal Minister of Education and Research, opened the Conference.

© Helmholtz Zentrum München

Federal Minister Karliczek emphasized the growing need of improved therapeutics to treat the rising global epidemic. In this regard, she highlighted Germany’s dedication to promoting excellence in science and praised the contribution of Helmholtz Zentrum München and its Diabetes Center. Watch the full speech of Anja Karliczek:

During his welcoming note Matthias Tschöp, CEO of Helmholtz Zentrum München, underlined the importance of interdisciplinary research and how, when done methodically, it makes breakthroughs towards a healthier society possible. “Particularly in biomedical research we have experienced that the creation of hubs which integrate biology, medicine, engineering and data science accelerates the translation into tangible medical solutions,” said Tschöp.

The Helmholtz Diabetes Center leads by example in building bridges locally, nationally and internationally to enhance research outputs. Its close collaborations with the German Center for Diabetes Research (DZD), the local universities but also with industry demonstrate its influential role in the diabetes world.  In line with the transfer strategy of Helmholtz Zentrum München it is leading the way in commercializing discoveries. 

“Our vision is ambitious but also within our grasp: to prevent type 1 diabetes and making type 2 diabetes a more livable condition, said Stephan Herzig, Director of the Helmholtz Diabetes Center. “We develop combination therapies against long-term effects of the disease, we discovered a novel drug target for diabetes remission, we have unique population-based studies in place to detect and prevent diabetes in children and there already is a very promising substance in clinical trial to treat both diabetes and obesity. We will continue our work for the benefit of society.”

The Diabetes Center also gives back to the scientific community by educating the next generation of scientific leaders with initiatives like the International Diabetes Research School. The center is also engaged to support knowledge transfer by information services that annually reach millions of patients and interested citizens. 

The Diabetes Conference will run until May 12th and is streamed live from the HelmholtzZentrum München campus.